Inventor · disambiguated record
Hans-Georg Lerchen
Also filed as: LERCHEN HANS-GEORG
48 granted patents·41 pending applications·510 citations·filing 1994–2024
98Inventor score
Top patents by PatentIndex Score
89 records- 0195US11478554B2Antibody drug conjugates (ADCS) having enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Oct 25, 2022·5 cites·20 claims
- 0294US10973923B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2016·Granted Apr 13, 2021·8 cites·37 claims
- 0394US10022453B2Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)Bayer Pharma AG·Filed 2014·Granted Jul 17, 2018·16 cites·39 claims
- 0492US11643469B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2022·Granted May 9, 2023·1 cites·15 claims
- 0592US11123439B2Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groupsBayer Pharma AG·Filed 2016·Granted Sep 21, 2021·8 cites·51 claims
- 0692US10744205B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodiesBayer Pharma AG·Filed 2016·Granted Aug 18, 2020·9 cites·28 claims
- 0792US8992932B2Binder-drug conjugates (ADCs) and use thereofSEATTLE GENETICS INC·Filed 2012·Granted Mar 31, 2015·26 cites·12 claims
- 0891US11660351B2Antibody drug conjugates (ADCs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted May 30, 2023·5 cites·50 claims
- 0990US11001636B2Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodiesBayer Pharma AG·Filed 2017·Granted May 11, 2021·5 cites·15 claims
- 1090US5777075AOctacyclodepsipeptides having an endoparasiticidal actionBAYER AG·Filed 1995·Granted Jul 7, 1998·36 cites·5 claims
- 1189US11071788B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBayer Pharma AG·Filed 2016·Granted Jul 27, 2021·6 cites·32 claims
- 1289US10485880B2Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodiesBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·11 cites·29 claims
- 1389US5874438A2,2'-bridged bis-2,4-diaminoquinazolinesBAYER AG·Filed 1996·Granted Feb 23, 1999·57 cites·18 claims
- 1488US6156754AGlycoconjugates of modified camptothecin derivatives (A-or B-ring linkage)BAYER AG·Filed 1997·Granted Dec 5, 2000·89 cites·10 claims
- 1587US11685714B2Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted Jun 27, 2023·3 cites·30 claims
- 1685US8420825B2Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugsVAKALOPOULOS ALEXANDROS·Filed 2010·Granted Apr 16, 2013·10 cites·29 claims
- 1784US8987209B2N-carboxyalkyl-auristatin and the use thereofLERCHEN HANS-GEORG·Filed 2011·Granted Mar 24, 2015·6 cites·16 claims
- 1884US8101601B2Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disordersLERCHEN HANS-GEORG·Filed 2007·Granted Jan 24, 2012·6 cites·4 claims
- 1984US5760230A4, 4'-bridged bis-2, 4-diaminoquinazolinesBAYER AG·Filed 1996·Granted Jun 2, 1998·38 cites·7 claims
- 2083US8772498B2Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereofBAYER IP GMBH·Filed 2013·Granted Jul 8, 2014·5 cites·7 claims
- 2182US8722629B2Auristatin derivatives and use thereofLERCHEN HANS-GEORG·Filed 2011·Granted May 13, 2014·3 cites·21 claims
- 2282US6369028B1Octacyclodepsipeptides having an endoparasiticidal actionBAYER AG·Filed 1994·Granted Apr 9, 2002·20 cites·8 claims
- 2381US9029406B2N-carboxyalkylauristatins and use thereofLERCHEN HANS-GEORG·Filed 2012·Granted May 12, 2015·6 cites·13 claims
- 2481US2023399411A1Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodiesBayer Pharma AG·Filed 2023·Application pending·0 cites
- 2580US8703696B2Dipeptoid prodrugs and the use thereofLERCHEN HANS-GEORG·Filed 2008·Granted Apr 22, 2014·3 cites·8 claims
- 2680US2025099600A1Active Metabolites of Kinesin Spindle Protein Inhibitor ConjugatesBayer Pharma AG·Filed 2024·Application pending·0 cites
- 2779US8362015B2Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disordersBAYER IP GMBH·Filed 2007·Granted Jan 29, 2013·2 cites·5 claims
- 2876US2024325553A1Cytostatic conjugates with integrin ligandsBayer Pharma AG·Filed 2024·Application pending·0 cites
- 2975US8741834B2Dipeptoid prodrugs and the use thereofLERCHEN HANS-GEORG·Filed 2009·Granted Jun 3, 2014·2 cites·8 claims
- 3075US2023338559A1Antibody drug conjugates (adcs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2023·Application pending·0 cites
- 3174US8957017B2Dipeptoid prodrugs and their useBAYER IP GMBH·Filed 2014·Granted Feb 17, 2015·1 cites·7 claims
- 3274US8334284B2Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disordersLERCHEN HANS-GEORG·Filed 2011·Granted Dec 18, 2012·2 cites·15 claims
- 3373US12059472B2Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBAYER AG·Filed 2017·Granted Aug 13, 2024·1 cites·15 claims
- 3473US6649647B1Trioxane derivativesFiled 1999·Granted Nov 18, 2003·26 cites·7 claims
- 3572US7132295B2Isotopically coded affinity markers 3BAYER AG·Filed 2002·Granted Nov 7, 2006·5 cites·10 claims
- 3671US9040566B2Adenosine A1 agonists for the treatment of glaucoma and ocular hypertensionKLAR JÜRGEN·Filed 2011·Granted May 26, 2015·2 cites·11 claims
- 3771US2021230284A1Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodiesBayer Pharma AG·Filed 2021·Application pending·0 cites
- 3870US6468966B1Octacyclodepsipeptides having an endoparasiticidal actionBAYER AG·Filed 1994·Granted Oct 22, 2002·19 cites·6 claims
- 3970US2024043379A1Prodrugs of cytotoxic active agents having enzymatically cleavable groupsBayer Pharma AG·Filed 2023·Application pending·0 cites
- 4069US7304037B2Cytostatic conjugates with integrin ligandsBAYER AG·Filed 2002·Granted Dec 4, 2007·4 cites·17 claims
- 4169US5717063AOctacyclodepsipeptides having an endoparasiticidal actionBAYER AG·Filed 1995·Granted Feb 10, 1998·28 cites·3 claims
- 4268US12144865B2Antibody drug conjugates with enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Nov 19, 2024·0 cites·33 claims
- 4368US9315543B2Tyrosine based linkers for the releasable connection of peptidesBAYER IP GMBH·Filed 2012·Granted Apr 19, 2016·1 cites·6 claims
- 4466US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 4565US2022362392A1Specific antibody drug conjugates (adcs) having ksp inhibitorsBayer Pharma AG·Filed 2022·Application pending·0 cites
- 4664US11806404B2Site specific homogeneous with KSP inhibitorsBayer Pharma AG·Filed 2021·Granted Nov 7, 2023·0 cites·18 claims
- 4762US10035818B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBayer Pharma AG·Filed 2017·Granted Jul 31, 2018·0 cites·3 claims
- 4861US11433140B2Specific antibody drug conjugates (ADCs) having KSP inhibitorsBayer Pharma AG·Filed 2017·Granted Sep 6, 2022·0 cites·9 claims
- 4961US2021386864A1Cytostatic conjugates with integrin ligandsBayer Pharma AG·Filed 2019·Application pending·0 cites
- 5061US2015030618A1Novel binder-drug conjugates (adcs) and use thereofSEATTLE GENETICS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hans-Georg Lerchen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →